Affimed (0HL9.L) Stock Price
$0 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
1 -
Technical
2
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Affimed, AI stock picks, stock alerts and much more.
0HL9.L AI Stock Analysis
AI stock analysis for 0HL9.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Affimed (0HL9.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Affimed (0HL9.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Affimed (0HL9.L), currently trading at $0, will... Sign up to access price prediction.
About 0HL9.L
-
Affimed N.
-
Symbol
0HL9.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
1540
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$388.2 1.1% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$144.8 1.4% |
6 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$7.92 0.5% |
5 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$5.71 0% |
4 |
 |
Esperion Therapeutics 0IIM.L |
$2.75 0.2% |
6 |
News
0HL9.L Alternative Data
Web Traffic
Affimed receives an estimated 4694 monthly visitors to affimed.com.
-
Web Traffic
4694
-
Change from Previous Month
21%
-
3 Month Change
43.7%
-
YoY Change
43.7%
Twitter Followers
Affimed has 763 Twitter Followers on its main Twitter (also known as X) account.
-
Twitter Followers
763
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.1%
-
YoY Change
0.1%
LinkedIn Followers
7,095 are following Affimed on LinkedIn, up by 0.5% over the last month.
-
LinkedIn Followers
7095
-
Daily Change
0.5%
-
1 Month Change
0.5%
-
3 Month Change
1.5%
-
YoY Change
1.5%
LinkedIn Employees
According to LinkedIn, Affimed has 66 employees, down by -10.8% over the last month.
-
LinkedIn Employees
66
-
Daily Change
10.8%
-
1 Month Change
10.8%
-
3 Month Change
18.5%
-
YoY Change
18.5%
News Mentions
Affimed was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
Affimed has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
-
3 Month Change
0%
0HL9.L Financials
0HL9.L Key Metrics
-
Total Revenue
€155K
-
Net Income
-€15.1M
-
Earnings per Share
€0
-
Free cash flow
-€11.1M
-
EBITDA
-€14.4M
-
EBITDA Ratio
-93.2
-
Total Assets
€40M
0HL9.L 2-year Revenue & Income
0HL9.L 2-year Free Cash Flow
0HL9.L Technicals
0HL9.L SMA
0HL9.L RSI
FAQ
What's the current price of Affimed (0HL9.L) Stock?
The price of an Affimed (0HL9.L) share is $0.
What's the market cap of Affimed?
The current market cap of Affimed is 1540.
What are some stocks similar to Affimed (0HL9.L) that investors often compare it to?
Affimed (0HL9.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Esperion Therapeutics.
What is the forecast for Affimed's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Affimed's stock price to be around $0 in 2026. Starting from the current price of $0, this represents a 0% change in price, indicating a neutral outlook for the stock.
How to buy Affimed (0HL9.L) Stock?
Affimed stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Affimed shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.